[Retinopathy of prematurity. Prevention, screening and treatment guidelines]

J R Castro Conde1, I Echániz Urcelay, F Botet Mussons

  • 1Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife. jcastro@ull.es

Insights

Retinopathy of prematurity (ROP) screening lacks consistent criteria in Spain. This report provides evidence-based recommendations for ROP prevention, screening, treatment, and follow-up to standardize care.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Context:

  • Retinopathy of prematurity (ROP) screening is a critical component of neonatal care in Spanish hospitals.
  • Current practices for ROP screening exhibit significant variability in criteria and procedural aspects.
  • A need exists for standardized guidelines to ensure consistent and effective ROP management.

Purpose:

  • To establish evidence-based recommendations for the prevention, screening, treatment, and follow-up of retinopathy of prematurity in Spain.
  • To harmonize ROP care protocols across Spanish healthcare facilities.
  • To provide a comprehensive review of current literature and international guidelines.

Summary:

  • This review synthesizes the latest scientific evidence and guidelines from prominent organizations like the American Academy of Pediatrics (AAP) and the UK's updated recommendations.
  • Recommended prevention strategies align with optimal neonatal care practices.
  • Screening standards are defined by specific parameters: birth weight (≤1,500 g), gestational age (≤32 weeks), and clinical course instability.

Impact:

  • Implementation of these recommendations aims to improve the standardization and quality of ROP screening and management in Spain.
  • Consistent application of guidelines can lead to better outcomes for premature infants at risk of ROP.
  • This initiative supports the development of organized ROP service delivery models.